Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers.

Germline CHEK2*1100delC mutations in breast cancer patients with multiple primary cancers. J Med Genet. 2004 Nov; 41(11):e120.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.